Fortrea Holdings Inc. was noted for underperforming the market index this year, while Incepta Pharmaceuticals belongs to the relevant industry sector.
4 reports, 2 independent
Updated Aug 11
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 1
- Repetition
- 75%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Fortrea Holdings Inc. was noted for underperforming the market index this year, while Incepta Pharmaceuticals belongs to the relevant industry sector.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- ZacksFortrea Holdings Inc. (FTRE) Beats Q2 Earnings and Revenue Estimates Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.06 pe
- Insider MonkeyCurreen Capital’s Investment Thesis for Fortrea Holdings Inc (FTRE) Investment management company Curreen Capital released its second-quarter 2025 Investor letter. A copy of the letter can be downloa